Hybrid inhibitors of DNA and HDACs remarkably enhance cytotoxicity in leukaemia cells
Chlorambucil is a nitrogen mustard-based DNA alkylating drug, which is widely used as a front-line treatment of chronic lymphocytic leukaemia (CLL). Despite its widespread application and success for the initial treatment of leukaemia, a majority of patients eventually develop acquired resistance to...
Saved in:
Main Authors: | Yoojin Song (Author), Sun You Park (Author), Zhexue Wu (Author), Kwang-Hyeon Liu (Author), Young Ho Seo (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Synthesis, Antiplasmodial, and Antileukemia Activity of Dihydroartemisinin-HDAC Inhibitor Hybrids as Multitarget Drugs
by: Lukas von Bredow, et al.
Published: (2022) -
Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors
by: Elizabeth A. Thomas
Published: (2014) -
The efficacy of HDAC inhibitors in neoplasm treatment
by: Dominika Psiuk, et al.
Published: (2020) -
Nanomaterials as potential transporters of HDAC inhibitors
by: Cristabelle De Souza, et al.
Published: (2020) -
Effects of structurally distinct human HDAC6 and HDAC6/HDAC8 inhibitors against S. mansoni larval and adult worm stages.
by: Roberto Gimmelli, et al.
Published: (2024)